| __timestamp | ADMA Biologics, Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 5915545 | 91813000 |
| Thursday, January 1, 2015 | 7177633 | 178203000 |
| Friday, January 1, 2016 | 10661037 | 216080000 |
| Sunday, January 1, 2017 | 22760560 | 241203000 |
| Monday, January 1, 2018 | 16985290 | 214109000 |
| Tuesday, January 1, 2019 | 29349083 | 204890000 |
| Wednesday, January 1, 2020 | 42219783 | 227976000 |
| Friday, January 1, 2021 | 80942625 | 356128000 |
| Saturday, January 1, 2022 | 154079692 | 426409000 |
| Sunday, January 1, 2023 | 258214999 | 837999000 |
In pursuit of knowledge
In the dynamic world of biopharmaceuticals, revenue growth is a key indicator of a company's success. Over the past decade, ADMA Biologics, Inc. and HUTCHMED (China) Limited have showcased contrasting trajectories. ADMA Biologics, starting with a modest revenue in 2014, has seen a staggering increase of over 4,200% by 2023. This growth reflects their strategic advancements in immunotherapy and plasma-derived products. Meanwhile, HUTCHMED, a leader in innovative oncology and immunology therapies, has consistently outperformed, with revenues growing by approximately 800% over the same period. By 2023, HUTCHMED's revenue was more than three times that of ADMA, highlighting its dominant market position. This comparison not only underscores the competitive landscape of the biopharma industry but also emphasizes the importance of innovation and strategic market positioning in driving financial success.
Revenue Showdown: Bristol-Myers Squibb Company vs ADMA Biologics, Inc.
Breaking Down Revenue Trends: Gilead Sciences, Inc. vs ADMA Biologics, Inc.
Breaking Down Revenue Trends: Zoetis Inc. vs HUTCHMED (China) Limited
Revenue Insights: Takeda Pharmaceutical Company Limited and ADMA Biologics, Inc. Performance Compared
Breaking Down Revenue Trends: Teva Pharmaceutical Industries Limited vs ADMA Biologics, Inc.
Corcept Therapeutics Incorporated vs HUTCHMED (China) Limited: Annual Revenue Growth Compared
Telix Pharmaceuticals Limited vs ADMA Biologics, Inc.: Examining Key Revenue Metrics
Annual Revenue Comparison: Alkermes plc vs ADMA Biologics, Inc.
Breaking Down Revenue Trends: ADMA Biologics, Inc. vs Mesoblast Limited
ADMA Biologics, Inc. and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
ADMA Biologics, Inc. and Xencor, Inc.: A Comprehensive Revenue Analysis
HUTCHMED (China) Limited vs Arrowhead Pharmaceuticals, Inc.: Annual Revenue Growth Compared